Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
YesterdayDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
YesterdayRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
YesterdayThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
YesterdayBuffalo Potash Files Annual Information Form and New Technical Report
YesterdayIonik Announces 30-Day Extension of Senior Debt Facility
Therma Bright Inc. logo

Therma Bright Inc.

About

0.06CAD+0.00 +0.00%
Closed • Updated at 16:56 GMT+00:00
Market Cap$2.44M
Volume392
Beta1.55
RSI45.54
Gross Margin-12.68%
Health TechnologyMedical Specialties

Therma Bright Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 5 2026
Therma Bright Announces Follow-On Order from Horizon Health as Venowave(TM) Gains Traction in U.S. Vascular Markets
Mar 31 2026
Therma Bright Signs New Strategic Customer, Horizon Health, Currently Selling over 35,000 Compression Products Annually
Feb 10 2026
Therma Bright Portfolio Update: Inretio Successfully Completes First-in-Human Cohort for PREVA(TM) Stroke Platform; Targets 2026 U.S. FDA Trial
Jan 20 2026
Therma Bright Sells an Additional 200-Units of Venowave(TM) to Strategic Distribution Partner Gen-X Med
Dec 18 2025
Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.

Community Chat

Ask AI

Try asking
6ix6ixAIEvents